MY CONTENT

The ASNR Standards and Guidelines Committee reviewed new research evidence on GBCA safety and its relevance to current MRI contrast administration guidelines for patients with CKD. The recommendations for CKD patients are that there is no longer a need to withhold group II GBCAs when medically indicated for diagnosis and that it is not necessary to check renal function for these agents.

A DSA-based flow quantification tool (AneurysmFlow) was used to measure blood flow vectors and velocities after contrast injection. Complex flow patterns were shown to be common in ruptured aneurysms and those with daughter sacs. Lowest mean aneurysm flow amplitude in the dome and daughter sacs indicated pathophysiologic changes linked to rupture. Also, hypertension, bifurcation location, and irregular shape of unruptured aneurysm were found to be independent rupture risk factors.